The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Ocular Diseases and Hypertension

고혈압성 안질환

  • Oh, Min Jin (Department of Ophthalmology, National Medical Center) ;
  • Lee, Soo Young (Department of Ophthalmology, National Medical Center)
  • Published : 2012.11.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004;351:2310-2317. https://doi.org/10.1056/NEJMra032865
  2. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl 2):B54-B64.
  3. Memarzadeh F, Ying-Lai M, Chung J, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2010; 51:2872-2877. https://doi.org/10.1167/iovs.08-2956
  4. Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-1101. https://doi.org/10.1016/j.ophtha.2010.01.058
  5. Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol 2011;59:123-136.
  6. Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 2009;116:1928-1936. https://doi.org/10.1016/j.ophtha.2009.03.006
  7. Hogg RE, Woodside JV, Gilchrist SE, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008;115:1046-1052. https://doi.org/10.1016/j.ophtha.2007.07.031
  8. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974;268:336-345. https://doi.org/10.1097/00000441-197412000-00004
  9. Van den Born BJ, Hulsman CA, Hoekstra JB, Schlingemann RO, van Montfrans GA. Value of routine funduscopy in patients with hypertension: systematic review. BMJ 2005;331:73. https://doi.org/10.1136/bmj.331.7508.73
  10. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992. https://doi.org/10.1097/00004872-200311000-00002
  11. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
  12. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet]. London: Royal College of Physicians (UK); 2011 Aug. Available from : http://www.ncbi.nlm.nih.gov/books/NBK83274.
  13. Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol 2005;89:1646-1654. https://doi.org/10.1136/bjo.2005.072546
  14. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213-227.
  15. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration: an analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128: 700-710.
  16. Risk factors for neovascular age-related macular degeneration: the Eye Disease Case-Control Study Group. Arch Ophthalmol 1992;110:1701-1708. https://doi.org/10.1001/archopht.1992.01080240041025
  17. Antioxidant status and neovascular age-related macular degeneration: Eye Disease Case-Control Study Group. Arch Ophthalmol 1993;111:104-109. https://doi.org/10.1001/archopht.1993.01090010108035
  18. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875-879. https://doi.org/10.1001/archopht.1989.01070010897038
  19. Boekhoorn SS, Vingerling JR, Witteman JC, Hofman A, de Jong PT. C-reactive protein level and risk of aging macula disorder: the Rotterdam Study. Arch Ophthalmol 2007;125:1396-1401. https://doi.org/10.1001/archopht.125.10.1396
  20. Saif MW, Mehra R. Incidence and management of bevacizumab- related toxicities in colorectal cancer. Expert Opin Drug Saf 2006;5:553-566. https://doi.org/10.1517/14740338.5.4.553
  21. Arevalo JF, Sanchez JG, Wu L, et al. Intravitreal bevacizumab for subfoveal choroidal neovascularization in agerelated macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Ophthalmology 2010;117:1974-1981. https://doi.org/10.1016/j.ophtha.2010.01.056
  22. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: the Rotterdam Study. Ophthalmology 1995;102:54-60.
  23. Klein BE, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005;89:284-287. https://doi.org/10.1136/bjo.2004.048710
  24. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol 1995;113:216-221. https://doi.org/10.1001/archopht.1995.01100020100038
  25. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-1293. https://doi.org/10.1016/S0161-6420(00)00138-X
  26. Kaiser HJ, Flammer J. Systemic hypotension: a risk factor for glaucomatous damage? Ophthalmologica 1991;203:105-108. https://doi.org/10.1159/000310234
  27. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38: UK Prospective Diabetes Study Group. BMJ 1998;317:703-713. Erratum in: BMJ 1999;318:29. https://doi.org/10.1136/bmj.317.7160.703
  28. Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health Studies. Ophthalmology 2005;112:540-547. https://doi.org/10.1016/j.ophtha.2004.10.039
  29. Wong TY, Scott IU. Clinical practice: retinal-vein occlusion. N Engl J Med 2010;363:2135-2144. https://doi.org/10.1056/NEJMcp1003934

Cited by

  1. Correlation and Odds Ratio between Circulatory Diseases and the Onset of Ocular Diseases vol.24, pp.2, 2012, https://doi.org/10.14479/jkoos.2019.24.2.169
  2. Effects of Blood Pressure and Glucose Levels on Visual Acuity vol.24, pp.2, 2012, https://doi.org/10.14479/jkoos.2019.24.2.181
  3. Analysis of Odd Ratio between Morbidity Type of Circulatory Diseases and the Prevalence of Ocular Diseases vol.25, pp.3, 2012, https://doi.org/10.14479/jkoos.2020.25.3.323